Author: Lyles A.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.15, Iss.2, 1999-02, pp. : 129-140
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Prescription drug costs are expected to rise by > 18%
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 249, 2000-01 ,pp. :
Prescription drug benefit costs rising for US employers
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 298, 2001-01 ,pp. :
Prescription drug costs for the elderly soar in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 372, 2002-01 ,pp. :
Intervention reduces fluoxetine use, costs in managed care
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. :
Intervention reduces fluoxetine use and costs in managed care
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :